These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1675602)

  • 61. [Aspirin and peptic ulcer].
    VIAR BAYO J
    Rev Esp Enferm Apar Dig Nutr; 1956; 15(3):607-12. PubMed ID: 13379861
    [No Abstract]   [Full Text] [Related]  

  • 62. Aspirin and ulcer.
    MUIR A; COSSAR IA
    Br Med J; 1955 Jul; 2(4930):7-12. PubMed ID: 14378624
    [No Abstract]   [Full Text] [Related]  

  • 63. Dose-response changes in organ weights and water contents following rectal administration of toxic doses of acetylsalicylic acid.
    Coldwell BB; Boyd EM
    Can J Physiol Pharmacol; 1968 Jan; 46(1):53-7. PubMed ID: 5642441
    [No Abstract]   [Full Text] [Related]  

  • 64. Prevention of aspirin-induced gastric ulceration in rats by alpha-methyldopa and disulfiram.
    Hemmati M; Rezvani A; Djahanguiri B
    Pharmacology; 1973; 9(6):374-6. PubMed ID: 4746893
    [No Abstract]   [Full Text] [Related]  

  • 65. Aspirin and the kidneys in patients with cerebral ischemia.
    Monreal M; Lafoz E; Solans R; Foz M; Moreno V; Pumarola D
    Stroke; 1987; 18(2):537-8. PubMed ID: 3564117
    [No Abstract]   [Full Text] [Related]  

  • 66. [What is the role of H2 receptor blockers today in ulcer therapy?].
    Creutzfeldt W
    Internist (Berl); 1996 Sep; 37(9):937-8. PubMed ID: 8964690
    [No Abstract]   [Full Text] [Related]  

  • 67. Helicobacter pylori infection and the risk of gastro-duodenal damage in symptomatic elderly chronic low-dose aspirin users: effect of antisecretory drugs.
    Pilotto A; Franceschi M; Leandro G; Longo MG; Perri F; Scarcelli C
    Age Ageing; 2004 Jul; 33(4):402-4. PubMed ID: 15226108
    [No Abstract]   [Full Text] [Related]  

  • 68. [Ulcer prevention in therapy with low-dose acetylsalicylic acid?].
    Koop H
    Dtsch Med Wochenschr; 1991 Jun; 116(25):996-7. PubMed ID: 1675602
    [No Abstract]   [Full Text] [Related]  

  • 69. Prevention of peptic ulceration in patients receiving NSAIDs.
    Ballinger A
    Br J Hosp Med; 1993 Jun 2-15; 49(11):767-72. PubMed ID: 8101464
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Steroid therapy and H2-receptor antagonists: pharmacoeconomic implications.
    Marcus P; McCauley DL
    Clin Pharmacol Ther; 1997 May; 61(5):503-8. PubMed ID: 9164412
    [No Abstract]   [Full Text] [Related]  

  • 71. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update.
    Dajani EZ; Agrawal NM
    J Physiol Pharmacol; 1995 Mar; 46(1):3-16. PubMed ID: 7599335
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.